Literature DB >> 16938013

Functional neuroimaging of working memory in schizophrenia: task performance as a moderating variable.

Jared X Van Snellenberg1, Ivan J Torres, Allen E Thornton.   

Abstract

Functional neuroimaging studies in schizophrenia have demonstrated abnormal activation of dorsolateral prefrontal cortex (DLPFC) during working memory (WM) performance. However, findings of increased and decreased activity have been reported. The authors used meta-analysis to investigate whether diverging results arise as a function of differential WM task performance between patients and control participants. Results indicate that the magnitude of the group difference in WM performance is a moderator of DLPFC activation differences, and concepts such as hypo- or hyperfrontality do not universally characterize WM findings in schizophrenia. Thus, the variability in the WM activation findings between participants with schizophrenia and control participants reflects the specific conditions under which WM functions are evaluated, not just the WM construct per se. ((c) 2006 APA, all rights reserved).

Entities:  

Mesh:

Year:  2006        PMID: 16938013     DOI: 10.1037/0894-4105.20.5.497

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  74 in total

Review 1.  Cognition in schizophrenia: core psychological and neural mechanisms.

Authors:  Deanna M Barch; Alan Ceaser
Journal:  Trends Cogn Sci       Date:  2011-12-12       Impact factor: 20.229

2.  CNTRICS imaging biomarkers selection: Working memory.

Authors:  Deanna M Barch; Holly Moore; Derek E Nee; Dara S Manoach; Steven J Luck
Journal:  Schizophr Bull       Date:  2011-11-10       Impact factor: 9.306

Review 3.  Goal representations and motivational drive in schizophrenia: the role of prefrontal-striatal interactions.

Authors:  Deanna M Barch; Erin C Dowd
Journal:  Schizophr Bull       Date:  2010-06-21       Impact factor: 9.306

4.  Amygdala recruitment in schizophrenia in response to aversive emotional material: a meta-analysis of neuroimaging studies.

Authors:  Alan Anticevic; Jared X Van Snellenberg; Rachel E Cohen; Grega Repovs; Erin C Dowd; Deanna M Barch
Journal:  Schizophr Bull       Date:  2010-12-01       Impact factor: 9.306

Review 5.  Altered cortical GABA neurotransmission in schizophrenia: insights into novel therapeutic strategies.

Authors:  Ana D Stan; David A Lewis
Journal:  Curr Pharm Biotechnol       Date:  2012-06       Impact factor: 2.837

6.  Cognitive symptoms facilitatory for diagnoses in neuropsychiatric disorders: executive functions and locus of control.

Authors:  Trevor Archer; Richard M Kostrzewa; Richard J Beninger; Tomas Palomo
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

Review 7.  Cell and receptor type-specific alterations in markers of GABA neurotransmission in the prefrontal cortex of subjects with schizophrenia.

Authors:  David A Lewis; Takanori Hashimoto; Harvey M Morris
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

8.  Nonsocial and social cognition in schizophrenia: current evidence and future directions.

Authors:  Michael F Green; William P Horan; Junghee Lee
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

Review 9.  The motivation and pleasure dimension of negative symptoms: neural substrates and behavioral outputs.

Authors:  Ann M Kring; Deanna M Barch
Journal:  Eur Neuropsychopharmacol       Date:  2014-01-22       Impact factor: 4.600

10.  Alterations in functional activation in euthymic bipolar disorder and schizophrenia during a working memory task.

Authors:  Liberty S Hamilton; Lori L Altshuler; Jennifer Townsend; Susan Y Bookheimer; Owen R Phillips; Jeffrey Fischer; Roger P Woods; John C Mazziotta; Arthur W Toga; Keith H Nuechterlein; Katherine L Narr
Journal:  Hum Brain Mapp       Date:  2009-12       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.